HEDERA 22 is active in the discovery of next generation biomolecules, mainly from soil bacteria, using bio IT predictive approaches. Based on its unique microorganisms collection, its expertise in microbiology, genomic and metabolomic biology, HEDERA 22 is building its own next generation biomolecules library with identified activity, which is made available for screening to partners for licensing or partnership. Its aim is to participate in the challenge for better health and a better planet by developing sustainable products for pharma and plant protection.